EUVIMEDEUVIMED entdecken
Open Access

Sentinel Lymph Node Biopsy after Neoadjuvant Chemotherapy in Breast Cancer Patients with Positive Nodes Using Low-Cost Dual Dye Technique: Identifying Factors Associated with Adequate False Negative Rate Threshold

Sanjay Kumar Yadav, Jayesh Chavda, Arpan Mishra, Dhananjaya Sharma, Shyam Ji Rawat, Rajesh Jain

Breast Care · 2024 · 19 (3) · 142-148

DOI: 10.1159/000538654 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Breast Care, online erschienen am 02.04.2024. Verfasst von Sanjay Kumar Yadav und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, NSCB Medical College, Jabalpur, India. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

In this study, we evaluated the feasibility of the sentinel lymph node (SLN) identification rate (SLN-IR) of fluorescein-guided sentinel lymph node biopsy (SLNB) in combination with methylene blue dye (MBD) and factors which can lead to a false negative rate (FNR) threshold of 10%.

Methods

This was a prospective cross-sectional non-randomized validation study in patients with post-neoadjuvant chemotherapy (NACT) clinically node negative axilla who were node positive prior to start of NACT. Patients underwent validation of SLNB using fluorescein (and blue LED light) and MBD. Axillary dissection was performed irrespective of SLNB histology. SLIN-IR and FNR were assessed and compared with various molecular subtypes.

Results

The SLNs were identified in 102 out of 120 (85%) post-NACT patients. The median number of sentinel lymph nodes identified was 2 (range 1–3). The SLN-IR using MBD was 85%, FD was 82.5%, and combined MBD FD was 85%. Two or more SLNs were removed in 72 patients and 11 patients had tumor in the rest of the axilla, resulting in an FNR of 17.4%. An FNR was 25% in case only one SLN was found, and it was 11.42% if two or more than two SLNs were excised.

Conclusions

This cohort study found that use of low-cost dual dyes in patients with positive axillary disease, rendered cN0 with NACT, with 2 or more negative SLNs with SLNB alone, results in an FNR of 11.4%. Her 2 positive and TNBC with 2 or more negative SLNs are associated with an FNR of <10%. However, the number of such patients was small and further studies with larger sample size are warranted to confirm these findings.

Schlagwörter

Stichwörter der Autor:innen

Breast cancerChemotherapyFluorescein sodiumSentinel lymph node biopsy

Autor:innen und Institutionen

  • Department of Surgery, NSCB Medical College, Jabalpur, India.
  • Department of Urology, NSCB Medical College, Jabalpur, India.
  • Department of Radiation Oncology, NSCB Medical College, Jabalpur, India.

Zitieren

APA

Yadav, S. K., Chavda, J., Mishra, A., Sharma, D., Rawat, S. J., & Jain, R. (2024). Sentinel Lymph Node Biopsy after Neoadjuvant Chemotherapy in Breast Cancer Patients with Positive Nodes Using Low-Cost Dual Dye Technique: Identifying Factors Associated with Adequate False Negative Rate Threshold. Breast Care, 19(3), 142-148. https://doi.org/10.1159/000538654

Vancouver

Yadav SK, Chavda J, Mishra A, Sharma D, Rawat SJ, Jain R. Sentinel Lymph Node Biopsy after Neoadjuvant Chemotherapy in Breast Cancer Patients with Positive Nodes Using Low-Cost Dual Dye Technique: Identifying Factors Associated with Adequate False Negative Rate Threshold. Breast Care. 2024;19(3):142-148. doi:10.1159/000538654

BibTeX
@article{Yadav2024,
  author = {Yadav, Sanjay Kumar and Chavda, Jayesh and Mishra, Arpan and Sharma, Dhananjaya and Rawat, Shyam Ji and Jain, Rajesh},
  title = {Sentinel Lymph Node Biopsy after Neoadjuvant Chemotherapy in Breast Cancer Patients with Positive Nodes Using Low-Cost Dual Dye Technique: Identifying Factors Associated with Adequate False Negative Rate Threshold},
  journal = {Breast Care},
  year = {2024},
  volume = {19},
  number = {3},
  pages = {142--148},
  doi = {10.1159/000538654}
}
Kostenlos starten →